A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET-Reference-Cited by-同舟云学术

A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood–Brain Barrier with (R)-11C-Verapamil and PET

Published:2009-11-12 Issue:12 Volume:50 Page:1954-1961
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Wagner Claudia C.,Bauer Martin,Karch Rudolf,Feurstein Thomas,Kopp Stephan,Chiba Peter,Kletter Kurt,Löscher Wolfgang,Müller Markus,Zeitlinger Markus,Langer Oliver

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference31 articles.

1. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases

2. Targeting multidrug resistance in cancer

3. Differential in Vivo Sensitivity to Inhibition of P-glycoprotein Located in Lymphocytes, Testes, and the Blood-Brain Barrier

4. Development of a P-Glycoprotein Knockout Model in Rodents to Define Species Differences in its Functional Effect at the Blood–brain Barrier

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain;Fluids and Barriers of the CNS;2024-08-05

2. Tolerability of tariquidar – A third generation P-gp inhibitor as add-on medication to antiseizure medications in drug-resistant epilepsy;Seizure: European Journal of Epilepsy;2024-07

3. The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond;Drug Resistance Updates;2024-03

4. Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics;Expert Opinion on Drug Delivery;2024-01-02

5. ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery;Pharmacological Reviews;2023-03-27